Bioregenx (BRGX) Total Non-Current Liabilities (2021)
Bioregenx (BRGX) recorded quarterly Total Non-Current Liabilities of $151399.0 in Q4 2021.
Bioregenx (BRGX) Total Non-Current Liabilities (2021) Analysis & Trends
Bioregenx's Total Non-Current Liabilities history runs 1 years deep, the most recent figure standing at $151399.0 for Q4 2021.
- In Q4 2021, Total Non-Current Liabilities changed N/A year-over-year to $151399.0; the TTM figure through Dec 2021 stood at $151399.0 (changed N/A YoY), while the FY2021 annual figure was $151399.0, changed N/A from the prior year.
- Total Non-Current Liabilities was $151399.0 for Q4 2021 at Bioregenx.
- In the past five years, Total Non-Current Liabilities ranged from a high of $151399.0 in Q4 2021 to a low of $151399.0 in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 24.83 Bn | 17.52 Bn | 662.02 Mn | 1.79 Bn |
| 2 | BrightSpring Health Services | 13.57 Bn | 12.69 Bn | 482.22 Mn | 4.20 Bn |
| 3 | Healthequity | 7.20 Bn | 6.93 Bn | 256.31 Mn | 1.12 Bn |
| 4 | Hinge Health | 5.42 Bn | 5.11 Bn | 154.23 Mn | - |
| 5 | 10x Genomics | 4.46 Bn | 3.92 Bn | 106.18 Mn | 200.21 Mn |
| 6 | Doximity | 3.81 Bn | 3.06 Bn | 125.97 Mn | 172.85 Mn |
| 7 | Waystar Holding | 3.52 Bn | 3.36 Bn | 268.04 Mn | 1.90 Bn |
| 8 | Privia Health | 2.94 Bn | 2.57 Bn | 595.71 Mn | 10.69 Mn |
| 9 | Omnicell | 1.76 Bn | 1.59 Bn | 140.36 Mn | 737.31 Mn |
| 10 | Bioregenx | - | - | 348,288.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 151,399.00 |